Federal government agency

National Cancer Institute Grants

20 open National Cancer Institute grants accepting applications right now. Historical giving: 2,843 grants totaling $1.8B.

Want AI mission-fit scoring on National Cancer Institute opportunities? Start a free trial.

All-time tracked giving
$1.8B
2,843 grants
Median grant size
$427K
Max: $83M

Open National Cancer Institute grants

  • Strategically Engineered Multi-Antigen KSHV Vaccine: Integrating Humoral and Cellular Immunity for Effective Protection

    Up to $4.9MDeadline: Jul 31, 2029open

    /Abstract Infection of Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8), is estimated to account for 34,000 ne...

  • Conversational Agent to Improve Guideline Concordant Care for People with Cervical Cancer Screening Abnormalities

    Up to $3.3MDeadline: Jul 31, 2029open

    / ABSTRACT Cervical cancer is almost entirely preventable with appropriate screening and management of abnormal results, yet in the US, over 14,000 in...

  • Magnetic Resonance Fingerprinting of Glutamate Metabolism for Guiding Glioma Cancer Care

    Up to $3.2MDeadline: Jul 31, 2029open

    Glioblastoma (GBM) is the most common type of malignant primary brain tumor found in adults and is fatal in all cases with a median survival time of o...

  • Controllable solid tumor immunotherapy based on a wireless thermos-activator

    Up to $3.0MDeadline: Jul 31, 2029open

    Chimeric Antigen Receptor (CAR) T cell therapy is a groundbreaking treatment for cancer, with the potential to elicit long-lasting immune responses. H...

  • Non-invasive etiology-adjusted precision liver cancer risk prediction

    Up to $2.9MDeadline: Jul 31, 2029open

    Hepatocellular carcinoma (HCC) is the major histological type of liver cancer, caused by viral (HBV, HCV) and metabolic (alcohol, metabolic dysfunctio...

  • Impact of CAR and Nrf2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxification

    Up to $2.8MDeadline: Jul 30, 2029open

    Cyclophosphamide (CPA) and doxorubicin (DOX)-containing regimens are extensively utilized in treating various malignancies, including triple-negative ...

  • Supporting Informed Parental Decisions on HPV Vaccination through Safe and Personalized AI-Driven Conversations

    Up to $2.8MDeadline: Jul 31, 2029open

    This project aims to support informed decision making about Human Papillomavirus (HPV) vaccination among parents of adolescents in the United States t...

  • New methods to measure and interrupt metabolic fluxes in brain cancer

    Up to $2.8MDeadline: Jul 31, 2029open

    Glioblastomas (GBMs) are deadly incurable brain cancers that are treated with resection followed by radiation, which is often combined with chemothera...

  • Determining the function of medium to large diameter sensory neurons in paclitaxel-induced pain via large-scale in vivo DRG imaging

    Up to $2.7MDeadline: Jul 31, 2030open

    Paclitaxel-induced peripheral neuropathy (PIPN) is a common painful treatment side effect that affects millions of cancer patients. Currently there ar...

  • Nanotechnology enabled quantitative imaging of dendritic cell anti-cancer vaccines

    Up to $2.6MDeadline: Jul 31, 2029open

    Dendritic cells (DCs) are pivotal in mediating anti-tumor immunity, and an effective DC vaccine devoid of intolerable immune-related toxicity would be...

  • Fluorescence guided nerve sparing during colorectal cancer surgery using local application of a near infrared nerve fluorophore

    Up to $2.5MDeadline: Jul 31, 2029open

    Colorectal cancer (CRC) is the second leading cause of cancer death and is predicted to cause nearly 10% of cancer deaths worldwide in 2024. Rectal ca...

  • CP-CTNet Coordinating Center

    Up to $2.5MDeadline: Jul 31, 2031open

    /Abstract Cancer is the leading cause of morbidity and mortality in the US and in the world. One approach to reducing the risk and burden of cancer is...

  • Targeting Myeloid Metabolism to Reprogram the Tumor Microenvironment of Glioblastoma

    Up to $2.5MDeadline: Jul 31, 2029open

    IDH1R132H mutation is recognized as the most common initiating event for low-grade glioma and IDH1- mutant grade IV astrocytoma. Our recent study (Ste...

  • ROLE OF RNA SEQUESTRATION IN ACUTE MYELOID LEUKEMIA

    Up to $2.4MDeadline: Jul 31, 2029open

    Post-transcriptional mechanisms play crucial roles in maintenance of progenitor cell identity and have been implicated in cancer development, includin...

  • Convergent Epigenetic Control of Neuroendocrine Cancers

    Up to $2.4MDeadline: Mar 31, 2030open

    Summary (Overall) The overall goal of the Program “Convergent Epigenetic Control of Diverse Neuroendocrine Cancers” is to interrogate epigenetic and ...

  • The impact of dyadic processes on smoking and cigarette craving: An experimental investigation of romantic partners and smoking friends

    Up to $2.2MDeadline: Jul 31, 2029open

    Smoking is the leading preventable cause of cancer and mortality in the US, with Covid hitting smokers especially hard. Quitting is difficult (and smo...

  • FY25 TASK ORDER D - BASE: WO 126680 B539 EAST BASEMENT SWITCHBOARDREPLACEMENT. OPTION 1: 126680A B539 WEST ATTIC SWITCHBOARDREPLACEMENT

    Up to $2.0MDeadline: Mar 3, 2028open

    Base - The purpose of this project is to replace five aged switchboards in the East Basement of B539 with new code compliant switchboards. Additional ...

  • Principles of Speckle-Based Gene Regulation

    Up to $1.7MDeadline: Jul 31, 2028open

    The cell nucleus houses different types of non-DNA substructures, called nuclear bodies. Among these, nuclear speckles predominate. Speckles occupy ~1...

  • Deep Learning Serial Radiomics for Improved Cancer Therapy Response Assessment.

    Up to $1.7MDeadline: Jul 31, 2027open

    Summary This Direct to Phase II SBIR proposal aims to further develop and validate a deep learning radiomics biomarker for improved early response ass...

  • A Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and Balstilimab

    Up to $1.5MDeadline: Jul 31, 2028open

    Metastatic microsatellite stable colorectal cancer (MSS-CRC) accounts for 80% of CRCs with a standard of care that provides a dismal 10% objective res...

Where National Cancer Institute grants go

Recent grant recipients are concentrated in these states. Funders sometimes fund outside their primary states for high-fit projects, so don't self-eliminate solely on geography — check each opportunity's stated eligibility.

CANYTXMAPANCMDOHILFL

What National Cancer Institute funds

Top program areas based on GrantMind's analysis of recent National Cancer Institute awards:

Cancer Research

How to apply for National Cancer Institute grants

Most National Cancer Institute applications require: an organizational profile with mission and programs, a project proposal aligned with the funder's stated priorities, a project budget, and supporting attachments (IRS determination letter, board list, recent financials). Federal applicants additionally need a SAM.gov UEI and an active Grants.gov account.

Read: How to write a Letter of Inquiry that gets you invited to apply

Find every National Cancer Institute opportunity matched to your mission

Not sure where to start? Paste your website and get your three best-matched grants free — no account needed. Or start a free trial for AI mission-fit scoring across National Cancer Institute and 100,000+ other active funders, with proposals tuned to each funder's stated priorities.

Match: no account needed · Trial: no credit card required